Insiders / Mubadala Investment Co PJSC
Mubadala Investment Co PJSC
CIK 1704268institutionfundbeneficial ownerinsider
Companies
5
First seen
Jan 14, 2021
Last activity
Aug 14, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| MidCap Apollo Institutional Private Lending | 14,561,742 | — |
| Recursion Pharmaceuticals, Inc. · RXRX | 7,062,869 | — |
| Endeavor Group Holdings, Inc. · EDR | 2,232,747 | — |
| Blue Owl Technology Finance Corp. II | — | — |
| NextGen Acquisition Corp. II · NGCA | — | — |
All securities held
4 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Blue Owl Technology Finance Corp. II | Common stock | 31,965,864 |
| MidCap Apollo Institutional Private Lending | Common stock | 14,561,742 |
| Recursion Pharmaceuticals, Inc. | Class A common stock | 7,062,869 |
Other
| Company | Security | Shares |
|---|---|---|
| Recursion Pharmaceuticals, Inc. | Unclassified | 8,740,917 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 24, 2025 | Other Other (per filing) | EDR Endeavor Group Holdings, Inc. Class A Common Stock | $61.40M | -2.2M -100.00% | 0 | low |
| Apr 16, 2021 | Buy Open-market buy | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | $50.00M | +2.8M | 2,777,777 0.52% of shares | high |
| Jun 14, 2024 | Buy Open-market buy | MidCap Apollo Institutional Private Lending Common Shares of Beneficial Interest | $43.26M | +1.7M |